Why Aphranel’s EU MDR approval could sharpen competition in CaHA dermal fillers
Aphranel’s CaHA filler has secured EU MDR certification. Find out what this means for regenerative aesthetics and Europe’s filler market.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Lumenis strengthens FoLix, ULTRApulse Alpha and Stellar M22 case with ASLMS data
Aesthetics needs stronger evidence. Lumenis is using ASLMS data to push lasers deeper into hair loss, skin and rhinophyma care.
Pharma & Biotech
Why Galderma is turning ALASTIN into a clinic workflow strategy, not just a skincare brand
Galderma’s ALASTIN Signature Practices aim to embed skincare into aesthetic workflows. Read what this means for clinics, competition, and growth.
Pharma & Biotech
Can AbbVie’s Juvéderm strategy turn subtle aesthetics into the next growth engine for fillers
AbbVie is repositioning Juvéderm for the “undetectable” aesthetics era. Read what this means for injectables, clinicians, and market competition.
Medical Devices & Diagnostics
From ingredients to devices: what BON Natural Life Limited’s apple mask means for medical aesthetics innovation
Explore how BON Natural Life Limited’s bio-electronic apple polyphenol mask could reshape medical aesthetics if clinical data holds up.
Medical Devices & Diagnostics
Cynosure Lutronic sets stage for global Mosaic 3D rollout with IMCAS 2026 momentum
Find out how Cynosure Lutronic’s Mosaic 3D laser device could redefine non-ablative resurfacing after CE mark approval under EU MDR.
Pharma & Biotech
Spiderwort Biotechnologies’ cellulose scaffolds show promise in spinal cord repair
Spiderwort’s spinal cord scaffold earns scientific validation as its dermal filler enters human trials Spiderwort Biotechnologies Inc. has reported two key developments in its cellulose-based regenerative platform, signaling a step forward in both neurorepair and aesthetic medicine. A peer-reviewed study published in Scientific Reports confirms that the company’s plant-derived scaffolds promote neural tissue repair and